Efficacy of add-on pregabalin in the treatment of Generalized Anxiety Disorder comorbid with Major Depressive Disorder: a double-blind placebo-controlled study.
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Pregabalin (Primary) ; Escitalopram
- Indications Generalised anxiety disorder; Major depressive disorder
- Focus Therapeutic Use
- 24 Mar 2017 Status changed from recruiting to completed.
- 30 Jul 2013 New trial record